Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

This study has been terminated.
Sponsor:
Information provided by:
Ipsen
ClinicalTrials.gov Identifier:
NCT00092287
First received: September 22, 2004
Last updated: February 25, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2004
  Estimated Primary Completion Date: No date given